Evidence map›Paper›PMID 36500701›Full record

ArticleMolecules (Basel, Switzerland)2022

The Anti-Multidrug-Resistant

Han Wu, Hongtong Chen, Jungan Zhang, Xinxin Hu, Chunyang Xie, Weiting Cao, Ziqi Zhao, Zengshuo Xiao, Yixin Ren, Luyao Dong and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Han WuSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Hongtong ChenBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Jungan ZhangSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Xinxin HuBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Chunyang XieBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Weiting CaoSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Ziqi ZhaoSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Zengshuo XiaoSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Yixin RenSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Luyao DongBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.ORCID 0000-0003-1932-4630
Peiyi SunBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xuefu YouBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.ORCID 0000-0003-2156-1408
Xinyi YangBeijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.ORCID 0000-0002-1052-7821
Wei HongJingjinji National Center of Technology Innovation, Beijing 100094, China.
Hao WangSchool of Pharmacy, Minzu University of China, Beijing 100081, China.ORCID 0000-0002-9971-1237
Chinese Academy of Medical Sciences & Peking Union Medical College · CNMinzu University of China · CN

Funding

National Natural Science Foundation of China No. 32141003National Natural Science Foundation of China No. 81960623National Natural Science Foundation of China No. 82173694The CAMS Innovation Fund for Medical Sciences (CIFMS) No. 2021-1-12M-039The CAMS Innovation Fund for Medical Sciences (CIFMS) No. 2021-I2M-1-055The Fundamental Research Funds for The Central Universities No. 2021-PT350-001The National Science and Technology Infrastructure of China No. National Pathogen Resource Center-NPRC-32
6 · The paper itself

Abstract

As a major public health problem, the prevalence of

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsFolic Acid AntagonistsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsQuinazolinesTetrahydrofolate DehydrogenaseAnti-Bacterial AgentsFolic Acid AntagonistsQuinazolinesTetrahydrofolate DehydrogenaseAcinetobacter baumanniidihydrofolate reductasemultidrug resistance

Identifiers

PMID36500701
PMCPMC9735644
OpenAlexW4311676890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.